Ma Xiaocui, Duan Yuyou, Jung Christine J, Wu Jian, VandeVoort Catherine A, Zern Mark A
Department of Internal Medicine, Transplant Research Program, University of California, Davis Medical Center, Sacramento, California 95817, USA.
Cloning Stem Cells. 2008 Dec;10(4):485-93. doi: 10.1089/clo.2007.0012.
Embryonic stem cells (ESC) hold great potential for the treatment of liver diseases. Here, we report the differentiation of rhesus macaque ESC along a hepatocyte lineage. The undifferentiated monkey ESC line, ORMES-6, was cultured in an optimal culture condition in an effort to differentiate them into hepatocyte-like cells in vitro. The functional efficacy of the differentiated hepatic cells was evaluated using RT-PCR for the expression of hepatocyte specific genes, and Western blot analysis and immunocytochemistry for hepatic proteins such as alpha-fetoprotein (AFP), albumin and alpha1-antitrypsin (alpha1-AT). Functional assays were performed using the periodic acid schiff (PAS) reaction and ELISA. The final yield of ESC-derived hepatocyte-like cells was measured by flow cytometry for cells that were transduced with a liver-specific lentivirus vector containing the alpha1-AT promoter driving the expression of green fluorescence protein (GFP). The treatment of monkey ESC with an optimal culture condition yielded hepatocyte-like cells that expressed albumin, alpha1-AT, AFP, hepatocyte nuclear factor 3beta, glucose-6-phophatase, and cytochrome P450 genes and proteins as determined by RT-PCR and Western blot analysis. Immunofluorescent staining showed the cells positive for albumin, AFP, and alpha1-AT. PAS staining demonstrated that the differentiated cells showed hepatocyte functional activity. Albumin could be detected in the medium after 20 days of differentiation. Flow cytometry data showed that 6.5 +/- 1.0% of the total differentiated cells were positive for GFP. These results suggest that by using a specific, empirically determined, culture condition, we were able to direct monkey ESC toward a hepatocyte lineage.
胚胎干细胞(ESC)在肝病治疗方面具有巨大潜力。在此,我们报告恒河猴ESC沿肝细胞谱系的分化情况。未分化的猴ESC系ORMES - 6在最佳培养条件下培养,旨在体外将其分化为肝细胞样细胞。通过逆转录聚合酶链反应(RT - PCR)检测肝细胞特异性基因的表达,采用蛋白质免疫印迹分析以及对甲胎蛋白(AFP)、白蛋白和α1 - 抗胰蛋白酶(α1 - AT)等肝脏蛋白进行免疫细胞化学,来评估分化后肝细胞的功能功效。使用过碘酸希夫(PAS)反应和酶联免疫吸附测定(ELISA)进行功能测定。通过流式细胞术检测用含有驱动绿色荧光蛋白(GFP)表达的α1 - AT启动子的肝脏特异性慢病毒载体转导的细胞,来测定ESC来源的肝细胞样细胞的最终产量。用最佳培养条件处理猴ESC产生了肝细胞样细胞,通过RT - PCR和蛋白质免疫印迹分析确定,这些细胞表达白蛋白、α1 - AT、AFP、肝细胞核因子3β、葡萄糖 - 6 - 磷酸酶和细胞色素P450基因及蛋白质。免疫荧光染色显示细胞对白蛋白、AFP和α1 - AT呈阳性。PAS染色表明分化后的细胞具有肝细胞功能活性。分化20天后可在培养基中检测到白蛋白。流式细胞术数据显示,在总分化细胞中,6.5±1.0%的细胞对GFP呈阳性。这些结果表明,通过使用特定的、根据经验确定的培养条件,我们能够将猴ESC导向肝细胞谱系。